Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magda Chlebus

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chinese Clinical Oncology|April 6, 2015
Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom's lawDuane Schulthess, Magda Chlebus, Richard Bergstrӧm, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 21, 2010
Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testingTroy Seidle, Sally Robinson, Tom Holmes, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributingGill Fleetwood, Magda Chlebus, Joachim Coenen, et al.
Laboratory Animals|November 21, 2019
The European Federation of the Pharmaceutical Industry and Associations' Research and Animal Welfare Group: Assessing and benchmarking 'Culture of Care' in the context of using animals for scientific purposeSally Robinson, Sue Sparrow, Bella Williams, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Drug Discovery Today|September 11, 2025
Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revisionSini M Eskola, Nick Sykes, Sabine Atzor, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2015
Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshopTzutzuy Ramirez, Sonja Beken, Magda Chlebus, et al.
Regulatory Toxicology and Pharmacology : RTP|August 12, 2018
One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspectiveGianni Dal Negro, Chantra Eskes, Susanne Belz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chinese Clinical Oncology|April 6, 2015
Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom's lawDuane Schulthess, Magda Chlebus, Richard Bergstrӧm, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 21, 2010
Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testingTroy Seidle, Sally Robinson, Tom Holmes, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|April 4, 2015
Making progress and gaining momentum in global 3Rs efforts: how the European pharmaceutical industry is contributingGill Fleetwood, Magda Chlebus, Joachim Coenen, et al.
Laboratory Animals|November 21, 2019
The European Federation of the Pharmaceutical Industry and Associations' Research and Animal Welfare Group: Assessing and benchmarking 'Culture of Care' in the context of using animals for scientific purposeSally Robinson, Sue Sparrow, Bella Williams, et al.
Drug Discovery Today|February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspectiveInkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Drug Discovery Today|September 11, 2025
Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revisionSini M Eskola, Nick Sykes, Sabine Atzor, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Regulatory Toxicology and Pharmacology : RTP|July 19, 2015
Knowledge sharing to facilitate regulatory decision-making in regard to alternatives to animal testing: Report of an EPAA workshopTzutzuy Ramirez, Sonja Beken, Magda Chlebus, et al.
Regulatory Toxicology and Pharmacology : RTP|August 12, 2018
One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspectiveGianni Dal Negro, Chantra Eskes, Susanne Belz, et al.
Pageof 1